The importance of defining the paraneoplastic neurologic disorders.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 10362830)

Published in N Engl J Med on June 10, 1999

Authors

R B Darnell

Articles by these authors

Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04

Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell (2001) 6.50

Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron (2000) 4.24

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol (2000) 3.61

Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell (2000) 3.59

A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing. Proc Natl Acad Sci U S A (2000) 3.11

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol (2001) 2.98

Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron (1993) 2.81

A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci (1997) 2.76

A novel adaptor-related protein complex. J Cell Biol (1996) 2.69

The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol Cell Biol (1997) 2.69

Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol Cell (2000) 2.39

The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci U S A (1998) 2.22

Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med (1998) 2.11

The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci (1996) 2.03

FMRP RNA targets: identification and validation. Genes Brain Behav (2005) 1.97

Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc Natl Acad Sci U S A (1999) 1.93

The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc Natl Acad Sci U S A (2000) 1.92

Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. Cell (1995) 1.81

ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci U S A (1998) 1.63

Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Structure (1999) 1.59

The splice of life: alternative splicing and neurological disease. Nat Rev Neurosci (2001) 1.57

Differential expression of the human gonadotropin alpha gene in ectopic and eutopic cells. Mol Cell Biol (1985) 1.53

cdr2-specific CTLs are detected in the blood of all patients with paraneoplastic cerebellar degeneration analyzed. Ann Neurol (2000) 1.42

The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev (1999) 1.32

Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu Rev Neurosci (2001) 1.29

Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors. Cancer Res (2000) 1.11

A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. J Neurosci (1997) 0.99

Independent regulation by sodium butyrate of gonadotropin alpha gene expression and cell cycle progression in HeLa cells. Mol Cell Biol (1984) 0.98

The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons. Neurosci Lett (1993) 0.94

Mouse chromosomal locations of nine genes encoding homologs of human paraneoplastic neurologic disorder antigens. Genomics (1997) 0.89

Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy. Prostate Cancer Prostatic Dis (2004) 0.84

Neuronal signaling through alternative splicing: some exons CaRRE. Sci STKE (2001) 0.83

Structure and expression of human placental hormone genes. Adv Exp Med Biol (1986) 0.78